190 related articles for article (PubMed ID: 21548940)
1. Regulation of PBX3 expression by androgen and Let-7d in prostate cancer.
Ramberg H; Alshbib A; Berge V; Svindland A; Taskén KA
Mol Cancer; 2011 May; 10():50. PubMed ID: 21548940
[TBL] [Abstract][Full Text] [Related]
2. PBX3 is a putative biomarker of aggressive prostate cancer.
Ramberg H; Grytli HH; Nygård S; Wang W; Ögren O; Zhao S; Løvf M; Katz B; Skotheim RI; Bjartell A; Eri LM; Berge V; Svindland A; Taskén KA
Int J Cancer; 2016 Oct; 139(8):1810-20. PubMed ID: 27273830
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.
Xiao S; Song B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740
[TBL] [Abstract][Full Text] [Related]
4. Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer.
Han HB; Gu J; Zuo HJ; Chen ZG; Zhao W; Li M; Ji DB; Lu YY; Zhang ZQ
J Pathol; 2012 Feb; 226(3):544-55. PubMed ID: 21984339
[TBL] [Abstract][Full Text] [Related]
5. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV
Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196
[TBL] [Abstract][Full Text] [Related]
6. PBX3/MEK/ERK1/2/LIN28/let-7b positive feedback loop enhances mesenchymal phenotype to promote glioblastoma migration and invasion.
Xu X; Bao Z; Liu Y; Jiang K; Zhi T; Wang D; Fan L; Liu N; Ji J
J Exp Clin Cancer Res; 2018 Jul; 37(1):158. PubMed ID: 30016974
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid regulates the expression of PBX1, PBX2, and PBX3 in P19 cells both transcriptionally and post-translationally.
Qin P; Haberbusch JM; Soprano KJ; Soprano DR
J Cell Biochem; 2004 May; 92(1):147-63. PubMed ID: 15095411
[TBL] [Abstract][Full Text] [Related]
8. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.
Kikugawa T; Kinugasa Y; Shiraishi K; Nanba D; Nakashiro K; Tanji N; Yokoyama M; Higashiyama S
Prostate; 2006 Jul; 66(10):1092-9. PubMed ID: 16637071
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
10. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.
Dai JL; Maiorino CA; Gkonos PJ; Burnstein KL
Steroids; 1996 Sep; 61(9):531-9. PubMed ID: 8883219
[TBL] [Abstract][Full Text] [Related]
11. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
12. PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer.
Lamprecht S; Kaller M; Schmidt EM; Blaj C; Schiergens TS; Engel J; Jung A; Hermeking H; Grünewald TGP; Kirchner T; Horst D
Clin Cancer Res; 2018 Apr; 24(8):1974-1986. PubMed ID: 29391352
[No Abstract] [Full Text] [Related]
13. MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.
Nadiminty N; Tummala R; Lou W; Zhu Y; Zhang J; Chen X; eVere White RW; Kung HJ; Evans CP; Gao AC
J Biol Chem; 2012 Jan; 287(2):1527-37. PubMed ID: 22128178
[TBL] [Abstract][Full Text] [Related]
14. Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells.
He ML; Yuan HQ; Jiang AL; Gong AY; Chen WW; Zhang PJ; Young CY; Zhang JY
Cancer; 2006 Jun; 106(12):2547-55. PubMed ID: 16691616
[TBL] [Abstract][Full Text] [Related]
15. TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.
Takayama K; Horie-Inoue K; Suzuki T; Urano T; Ikeda K; Fujimura T; Takahashi S; Homma Y; Ouchi Y; Inoue S
Mol Endocrinol; 2012 May; 26(5):748-61. PubMed ID: 22456197
[TBL] [Abstract][Full Text] [Related]
16. BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation.
Lempiäinen JK; Manjur ABMK; Malinen M; Ketola K; Niskanen EA; Palvimo JJ
Oncogene; 2020 Mar; 39(11):2391-2407. PubMed ID: 31925334
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53.
Li WF; Herkilini A; Tang Y; Huang P; Song GB; Miyagishi M; Kasim V; Wu SR
Acta Pharmacol Sin; 2021 Nov; 42(11):1888-1899. PubMed ID: 33526870
[TBL] [Abstract][Full Text] [Related]
18. Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.
Fletcher CE; Dart DA; Sita-Lumsden A; Cheng H; Rennie PS; Bevan CL
Hum Mol Genet; 2012 Jul; 21(14):3112-27. PubMed ID: 22505583
[TBL] [Abstract][Full Text] [Related]
19. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
20. MiR-320 inhibits the growth of glioma cells through downregulating PBX3.
Pan C; Gao H; Zheng N; Gao Q; Si Y; Zhao Y
Biol Res; 2017 Sep; 50(1):31. PubMed ID: 28934982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
